<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0" xml:base="http://group.iba-worldwide.com/news-and-press/all/2012">
  <channel>
    <title>IBA News and Press Releases</title>
    <link>http://group.iba-worldwide.com/news-and-press/all/2012</link>
    <description>IBA news</description>
    <language>en</language>
          <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/IbaNews" /><feedburner:info uri="ibanews" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item>
    <title>Cisbio Bioassays Adds Three Cellular Kinase Assays to its Kinase Screening Platform</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/bQiDuy6v0A4/cisbio-bioassays-adds-three-cellular-kinase-assays-its-kinase-screening-platform</link>
    <description />
     <pubDate>Fri, 11 May 2012 11:29:42 +0000</pubDate>
 <dc:creator>Sylvain.Coppens@iba-group.com</dc:creator>
 <guid isPermaLink="false">7862 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/cisbio-bioassays-adds-three-cellular-kinase-assays-its-kinase-screening-platform</feedburner:origLink></item>
  <item>
    <title>Trading update - First quarter 2012</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/zcYxQKQJggc/trading-update-first-quarter-2012</link>
    <description />
     <pubDate>Tue, 08 May 2012 18:21:30 +0000</pubDate>
 <dc:creator>Sylvain.Coppens@iba-group.com</dc:creator>
 <guid isPermaLink="false">7861 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/trading-update-first-quarter-2012</feedburner:origLink></item>
  <item>
    <title>Installation of IBA proton system begins at ATreP in Trento, Italy</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/ccegWd3gyxo/installation-iba-proton-system-begins-atrep-trento-italy</link>
    <description />
     <pubDate>Thu, 03 May 2012 09:05:39 +0000</pubDate>
 <dc:creator>Daniel.Ernult@iba-group.com</dc:creator>
 <guid isPermaLink="false">7843 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/installation-iba-proton-system-begins-atrep-trento-italy</feedburner:origLink></item>
  <item>
    <title>Information about a partial decision in the process of arbitration between STRIBA and WPE</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/0y25JTe3_-8/information-about-partial-decision-process-arbitration-between-striba-and-wpe</link>
    <description />
     <pubDate>Thu, 26 Apr 2012 16:00:02 +0000</pubDate>
 <dc:creator>Sylvain.Coppens@iba-group.com</dc:creator>
 <guid isPermaLink="false">7820 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/information-about-partial-decision-process-arbitration-between-striba-and-wpe</feedburner:origLink></item>
  <item>
    <title>IBA closes its IBA Molecular transaction with SK Capital and revises its 2011 Financial Statements accordingly</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/86QwOkNva_w/iba-closes-its-iba-molecular-transaction-sk-capital-and-revises-its-2011-financial-statements-accord</link>
    <description />
     <pubDate>Mon, 02 Apr 2012 15:41:07 +0000</pubDate>
 <dc:creator>Sylvain.Coppens@iba-group.com</dc:creator>
 <guid isPermaLink="false">7778 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/iba-closes-its-iba-molecular-transaction-sk-capital-and-revises-its-2011-financial-statements-accord</feedburner:origLink></item>
  <item>
    <title>Market Authorization obtained in Portugal for the 18F-FDG IBA Synthera® Autoclave process</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/2R4J5Jg8b4c/market-authorization-obtained-portugal-18f-fdg-iba-synthera%C2%AE-autoclave-process</link>
    <description />
     <pubDate>Thu, 22 Mar 2012 08:34:06 +0000</pubDate>
 <dc:creator>Sandy.Trips</dc:creator>
 <guid isPermaLink="false">7736 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/market-authorization-obtained-portugal-18f-fdg-iba-synthera%C2%AE-autoclave-process</feedburner:origLink></item>
  <item>
    <title>IBA Completes Proton System and First Treatment Room in Record Time</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/40exlvNwuLQ/iba-completes-proton-system-and-first-treatment-room-record-time</link>
    <description />
     <pubDate>Tue, 20 Mar 2012 16:06:54 +0000</pubDate>
 <dc:creator>Sylvain.Coppens@iba-group.com</dc:creator>
 <guid isPermaLink="false">7735 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/iba-completes-proton-system-and-first-treatment-room-record-time</feedburner:origLink></item>
  <item>
    <title>2011 Annual Results</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/xxoaeGmK5jg/2011-annual-results</link>
    <description />
     <pubDate>Thu, 15 Mar 2012 16:39:09 +0000</pubDate>
 <dc:creator>Sylvain.Coppens@iba-group.com</dc:creator>
 <guid isPermaLink="false">7722 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/2011-annual-results</feedburner:origLink></item>
  <item>
    <title>IBA Introduces Peer Review Program  for 18F Sodium Fluoride (NaF) PET/CT Bone Imaging </title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/JNv06VtHO4M/iba-introduces-peer-review-program-18f-sodium-fluoride-naf-petct-bone-imaging-0</link>
    <description />
     <pubDate>Fri, 02 Mar 2012 08:39:34 +0000</pubDate>
 <dc:creator>Sylvain.Coppens@iba-group.com</dc:creator>
 <guid isPermaLink="false">7681 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/iba-introduces-peer-review-program-18f-sodium-fluoride-naf-petct-bone-imaging-0</feedburner:origLink></item>
  <item>
    <title>IBA holds a Conference Call on the Partnership with SK Capital Partners - On Feb 13, 2012 - as from 6 pm (Brussels' time)</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/dqOVM2CFA-o/iba-holds-conference-call-partnership-sk-capital-partners-feb-13-2012-6-pm-brussels-time</link>
    <description />
     <pubDate>Fri, 10 Feb 2012 17:09:52 +0000</pubDate>
 <dc:creator>marie.gahylle</dc:creator>
 <guid isPermaLink="false">7635 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/iba-holds-conference-call-partnership-sk-capital-partners-feb-13-2012-6-pm-brussels-time</feedburner:origLink></item>
  <item>
    <title>IBA Announces New Chief Operating Officer and Leadership Succession Plan</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/wv5VmSUXN9M/iba-announces-new-chief-operating-officer-and-leadership-succession-plan</link>
    <description />
     <pubDate>Mon, 09 Jan 2012 07:29:03 +0000</pubDate>
 <dc:creator>Sandrine.Leriche</dc:creator>
 <guid isPermaLink="false">7554 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/iba-announces-new-chief-operating-officer-and-leadership-succession-plan</feedburner:origLink></item>
  <item>
    <title>IBA and SK CAPITAL PARTNERS Join to Accelerate Growth of IBA’s World-Leading Radiopharmaceutical Business</title>
    <link>http://feedproxy.google.com/~r/IbaNews/~3/YWV2PkAYS2w/iba-and-sk-capital-partners-join-accelerate-growth-iba%E2%80%99s-world-leading-radiopharmaceutical-business</link>
    <description />
     <pubDate>Mon, 09 Jan 2012 07:20:18 +0000</pubDate>
 <dc:creator>Sandrine.Leriche</dc:creator>
 <guid isPermaLink="false">7553 at http://group.iba-worldwide.com</guid>
  <feedburner:origLink>http://group.iba-worldwide.com/iba-and-sk-capital-partners-join-accelerate-growth-iba%E2%80%99s-world-leading-radiopharmaceutical-business</feedburner:origLink></item>
  </channel>
</rss>

